DRL-17822

DRL-17822 · Dr. Reddy's Laboratories Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DRL-17822, covering 2014-04-22 to 2014-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels [Phase 2]

See pricing